Transarterial-chemoembolization and hepatocellular carcinoma. A regular interval approach avoids the 10% of the procedures and an optimal survival with the transition to systemic therapy in 80% of the patients

Authors :: A. Sotomayor
Neus Llarch
Ernest Belmonte
Álvaro Díaz-González
Anna Darnell
Marco Sanduzzi Zamparelli
Marta Barrufet
Victor Sapena
Jordi Bruix
Marta Burrel
Gemma Iserte
Jordi Rimola
C. Ayuso
M. Reig
Alejandro Forner
Source :: Journal of Hepatology. 68:S205
Publication Year :: 2018
Publisher :: Elsevier BV, 2018.

Subjects :: medicine.medical_specialty
Hepatology
business.industry
Hepatocellular carcinoma
Medicine
Interval (graph theory)
Radiology
business
medicine.disease
Systemic therapy

Full Text Access

Tools